Baclofen and Msm drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Baclofen (baclofen) and Msm (methylsulfonylmethane). Common drug interactions include weight decreased among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Baclofen and Msm. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Baclofen?

Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,662 Baclofen users. Check the latest studies of Baclofen.

What is Msm?

Msm has active ingredients of methylsulfonylmethane. It is often used in joint pain. eHealthMe is studying from 1,210 Msm users. Check the latest studies of Msm.



On Jul, 20, 2026

24 people who take Baclofen and Msm together, and have interactions are studied.

Baclofen and Msm drug interactions.

What are the common drug interactions of Baclofen and Msm, by gender? *:

female:

  1. Weight decreased
  2. Abdominal distension
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
  5. Irritable bowel syndrome
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  7. Vaginal infection
  8. Vulvovaginal mycotic infection (vulvovaginal fungal infection)
  9. Gait disturbance
  10. Malaise (a feeling of general discomfort or uneasiness)

male:

  1. Asthenia (weakness)
  2. Back pain
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Distractibility (inability to sustain one's attention)
  5. Smoke sensitivity
  6. Temperature intolerance (inability to go in temperature)

What are the common drug interactions of Baclofen and Msm, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Distractibility (inability to sustain one's attention)

40-49:

  1. Ataxia (loss of full control of bodily movements)
  2. Dizziness
  3. Dysarthria (speech disorder)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  6. Muscle rigidity (muscle stiffness)
  7. Myalgia (muscle pain)
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Abdominal discomfort

50-59:

  1. Abdominal discomfort
  2. Chest discomfort
  3. Decreased appetite
  4. Drug ineffective
  5. Erythema (redness of the skin)
  6. Feeling hot
  7. Gait disturbance
  8. Masked facies (mask like facial expression, display little facial expression)
  9. Muscle twitching
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Diarrhoea
  2. Urinary tract infection
  3. Vaginal infection
  4. Vulvovaginal mycotic infection (vulvovaginal fungal infection)
  5. Asthenia (weakness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Blood urine present
  8. Cystitis (inflammation of the wall of the bladder)
  9. Fatigue (feeling of tiredness)
  10. Gait disturbance

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 25.00%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 16.67%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 12.50%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 12.50%
  5. Osteoporosis (bones weak and more likely to break): 2 people, 8.33%
  6. Gait Disturbance: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Baclofen and Msm?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Baclofen and Msm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Baclofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Msm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Baclofen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Msm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on baclofen and methylsulfonylmethane (the active ingredients of Baclofen and Msm, respectively), and Baclofen and Msm (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: